Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Other Non Operating Income (2016 - 2024)

Historic Other Non Operating Income for Collegium Pharmaceutical (COLL) over the last 4 years, with Q3 2024 value amounting to -$4.1 million.

  • Collegium Pharmaceutical's Other Non Operating Income changed N/A to -$4.1 million in Q3 2024 from the same period last year, while for Dec 2024 it was -$11.3 million, marking a year-over-year increase of 5179.97%. This contributed to the annual value of -$11.3 million for FY2024, which is 5179.97% up from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Other Non Operating Income of -$4.1 million as of Q3 2024.
  • Collegium Pharmaceutical's Other Non Operating Income's 5-year high stood at $23.5 million during Q1 2023, with a 5-year trough of -$47.0 million in Q2 2023.